Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer
- 1 May 2003
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 56 (1), 199-207
- https://doi.org/10.1016/s0360-3016(03)00086-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- Hypofractionation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate CancerJournal of Clinical Oncology, 2000
- Toward optimal external-beam fractionation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Cell production rates in human tissues and tumours and their significance. Part II: clinical dataEuropean Journal of Surgical Oncology, 2000
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation twenty-two years' experience (1962–1984)Urology, 1990
- Retrospective Study of Radiotherapy in Early Carcinoma of the ProstateBritish Journal of Urology, 1989